2014
DOI: 10.1007/s00044-014-1186-7
|View full text |Cite
|
Sign up to set email alerts
|

Prospective study directed to the synthesis of unsymmetrical linked bis-5-arylidene rhodanine derivatives via “one-pot two steps” reactions under microwave irradiation with their antitumor activity

Abstract: International audienceWe here report on the synthesis of new unsymmetrical linked bis-5-arylidene rhodanine derivatives with stereocontrolled Z-configuration. The 6 steps synthesis was achieved and the key steps are the construction of the two 5-arylidene rhodanine moieties using an “one-pot two-steps” method under microwave dielectric heating in a closed reactor. The intermediates 6, 7 and desired unsymmetrical compounds 9 have been also evaluated for their in vitro inhibition of cell proliferation (Huh7 D12,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
22
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(23 citation statements)
references
References 24 publications
0
22
0
Order By: Relevance
“…2-N,N 0 -Disubstituted diamines bearing 5-arylidene-4thiazolidinone moiety 136 (Scheme 69) had shown nanomolar inhibition potency (IC 50 40 nM) towards tyrosine phosphorylationregulated kinases 1A [333]. This result prompted to explore the symmetric 1,2-diamino-linker grafted on N-3 position of two different 5-arylidenerhodanine platforms in order to modulate potential biological activity and led to the synthesis of unsymmetrical linked bis-5-arylidenerhodanine derivatives with anticancer effects [334].…”
Section: Anticancer Agentsmentioning
confidence: 99%
“…2-N,N 0 -Disubstituted diamines bearing 5-arylidene-4thiazolidinone moiety 136 (Scheme 69) had shown nanomolar inhibition potency (IC 50 40 nM) towards tyrosine phosphorylationregulated kinases 1A [333]. This result prompted to explore the symmetric 1,2-diamino-linker grafted on N-3 position of two different 5-arylidenerhodanine platforms in order to modulate potential biological activity and led to the synthesis of unsymmetrical linked bis-5-arylidenerhodanine derivatives with anticancer effects [334].…”
Section: Anticancer Agentsmentioning
confidence: 99%
“…The 5-arylidene-2-thioxo-1,3-thiazolidinine-4-ones or 5-arylidene rhodanines are considered as ''privileged scaffolds'' in the medicinal chemistry community because they presented a bioactivity in a large range of derivatives [1][2][3][4][5] . For example, these small molecules have been known to possesses a wide range of biological properties such as potent and selective inhibitors of the ''atypical'' dual-specificity phosphatase (DSP)…”
Section: Unexpected Synthesis Of Novel 3-allyl-5-(arylidene)-2-thioxomentioning
confidence: 99%
“…2‐Thioxo‐4‐thiazolidinone, commonly known as “rhodanine,” as well as its derivatives possesses a broad spectrum of biological activity. Their antidiabetic, antifungal, antimicrobial, pesticidal, antiapoptotic, and anticancer activities are widely reported . The rhodanine moiety, possessing a variously substituted benzylidene group at C‐5, shows a moderate anticancer activity .…”
Section: Introductionmentioning
confidence: 99%